165 related articles for article (PubMed ID: 34311708)
21. Association of metabolic syndrome and sarcopenia with all-cause and cardiovascular mortality: a prospective cohort study based on the NHANES.
Huang W; Deng S; Liu S; Ma Q; Cao L; Liu L; Wan H; Shen J
Front Endocrinol (Lausanne); 2024; 15():1346669. PubMed ID: 38596221
[TBL] [Abstract][Full Text] [Related]
22. Incidence and long-term specific mortality trends of metabolic syndrome in the United States.
Li W; Qiu X; Ma H; Geng Q
Front Endocrinol (Lausanne); 2022; 13():1029736. PubMed ID: 36733801
[TBL] [Abstract][Full Text] [Related]
23. Low sensitivity for the metabolic syndrome to detect uric acid elevations in females and non-Hispanic-black male adolescents: an analysis of NHANES 1999-2006.
DeBoer MD; Gurka MJ
Atherosclerosis; 2012 Feb; 220(2):575-80. PubMed ID: 22178428
[TBL] [Abstract][Full Text] [Related]
24. Loss of Life Expectancy by 10 Years or More From Elevated Aspartate Aminotransferase: Finding Aspartate Aminotransferase a Better Mortality Predictor for All-Cause and Liver-Related than Alanine Aminotransferase.
Xie K; Chen CH; Tsai SP; Lu PJ; Wu H; Zeng Y; Ye Y; Tu H; Wen C; Huang M; Zhang Y; Lee JH; Tsai MK; Wen CP; Wu X
Am J Gastroenterol; 2019 Sep; 114(9):1478-1487. PubMed ID: 31425154
[TBL] [Abstract][Full Text] [Related]
25. Age- and sex- specific all-cause mortality risk greatest in metabolic syndrome combinations with elevated blood pressure from 7 U.S. cohorts.
Yu WW; Randhawa AK; Blair SN; Sui X; Kuk JL
PLoS One; 2019; 14(6):e0218307. PubMed ID: 31194821
[TBL] [Abstract][Full Text] [Related]
26. Patterns of clustering of the metabolic syndrome components and its association with coronary heart disease in the Multi-Ethnic Study of Atherosclerosis (MESA): A latent class analysis.
Riahi SM; Moamer S; Namdari M; Mokhayeri Y; Pourhoseingholi MA; Hashemi-Nazari SS
Int J Cardiol; 2018 Nov; 271():13-18. PubMed ID: 29885819
[TBL] [Abstract][Full Text] [Related]
27. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES.
Veeranna V; Zalawadiya SK; Panaich S; Patel KV; Afonso L
Int J Cardiol; 2013 Oct; 168(6):5156-61. PubMed ID: 24016543
[TBL] [Abstract][Full Text] [Related]
28. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.
Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D
J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819
[TBL] [Abstract][Full Text] [Related]
29. Risk factor-based subphenotyping of heart failure in the community.
Andersson C; Lyass A; Xanthakis V; Larson MG; Mitchell GF; Cheng S; Vasan RS
PLoS One; 2019; 14(10):e0222886. PubMed ID: 31613888
[TBL] [Abstract][Full Text] [Related]
30. Severity of metabolic syndrome is greater among nonalcoholic adults with elevated ALT and advanced fibrosis.
DeBoer MD; Lin B; Filipp SL; Cusi K; Gurka MJ
Nutr Res; 2021 Apr; 88():34-43. PubMed ID: 33743323
[TBL] [Abstract][Full Text] [Related]
31. Age, gender and metabolic syndrome-related coronary heart disease in U.S. adults.
Tong W; Lai H; Yang C; Ren S; Dai S; Lai S
Int J Cardiol; 2005 Oct; 104(3):288-91. PubMed ID: 16186058
[TBL] [Abstract][Full Text] [Related]
32. Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population.
Sierra-Johnson J; Fisher RM; Romero-Corral A; Somers VK; Lopez-Jimenez F; Ohrvik J; Walldius G; Hellenius ML; Hamsten A
Eur Heart J; 2009 Mar; 30(6):710-7. PubMed ID: 18676970
[TBL] [Abstract][Full Text] [Related]
33. The prevalence of elevated alanine transaminase and its possible causes in the general Korean population.
Hyun HJ; Shim JJ; Kim JW; Lee JS; Lee CK; Jang JY; Kim BH
J Clin Gastroenterol; 2014 Jul; 48(6):534-9. PubMed ID: 24275711
[TBL] [Abstract][Full Text] [Related]
34. Red blood cell folate concentrations and coronary heart disease prevalence: A cross-sectional study based on 1999-2012 National Health and Nutrition Examination Survey.
Peng Y; Wang Z
Nutr Metab Cardiovasc Dis; 2017 Nov; 27(11):1015-1020. PubMed ID: 28844321
[TBL] [Abstract][Full Text] [Related]
35. Alanine aminotransferase and metabolic syndrome in adolescents: the Korean National Health and Nutrition Examination Survey Study.
Park JH; Kim SH; Park S; Park MJ
Pediatr Obes; 2014 Dec; 9(6):411-8. PubMed ID: 24151157
[TBL] [Abstract][Full Text] [Related]
36. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study.
Ford ES
Atherosclerosis; 2004 Apr; 173(2):309-14. PubMed ID: 15064107
[TBL] [Abstract][Full Text] [Related]
37. Ethnic differences in the link between insulin resistance and elevated ALT.
Deboer MD; Wiener RC; Barnes BH; Gurka MJ
Pediatrics; 2013 Sep; 132(3):e718-26. PubMed ID: 23940240
[TBL] [Abstract][Full Text] [Related]
38. LV Mass as a Predictor of CVD Events in Older Adults With and Without Metabolic Syndrome and Diabetes.
Hoang K; Zhao Y; Gardin JM; Carnethon M; Mukamal K; Yanez D; Wong ND
JACC Cardiovasc Imaging; 2015 Sep; 8(9):1007-1015. PubMed ID: 26319502
[TBL] [Abstract][Full Text] [Related]
39. Elevated Liver Enzymes and Mortality in Older Individuals: A Prospective Cohort Study.
Mahady SE; Wong G; Turner RM; Mitchell P; Macaskill P; Craig JC; George J
J Clin Gastroenterol; 2017; 51(5):439-445. PubMed ID: 27479143
[TBL] [Abstract][Full Text] [Related]
40. Multiple biomarkers for mortality prediction in peripheral arterial disease.
Amrock SM; Weitzman M
Vasc Med; 2016 Apr; 21(2):105-12. PubMed ID: 26762418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
